Zaltrap approved for advanced colorectal cancer
(HealthDay) -- Zaltrap (ziv-afilbercept) has been approved by the U.S. Food and Drug Administration in combination with a FOLFIRI chemotherapy regimen for adults with advanced metastatic (spreading) colorectal cancer, the ...
Medications
Aug 04, 2012 |
not rated yet |
0
Discovering new uses for old drugs
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat ...
Medications
Aug 01, 2012 |
not rated yet |
0
Yale researchers enroll first patient in study of heart-preserving molecule
(Medical Xpress) -- A 69-year-old man became the first patient enrolled and treated in an ongoing study at Yale School of Medicine of BB3, a molecule that promises to preserve heart muscle, promote healing ...
Cardiology
Jul 24, 2012 |
5 / 5 (1) |
0
Better management of traumatic brain injury
New treatments to lessen the severity of the more than 21,000 Traumatic Brain Injury (TBI) cases that occur in Australia each year are on the horizon.
Neuroscience
Jul 19, 2012 |
5 / 5 (2) |
0
|
'Molecular grenade': Drug from Mediterranean weed kills tumor cells in mice
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by ...
Cancer
Jul 09, 2012 |
5 / 5 (18) |
2
|
US blood supply dips to 'emergency' level: Red Cross
The blood supply maintained by the US Red Cross has fallen to "emergency levels" as donations have ebbed due in part to an early warm weather spell, a spokeswoman said on Tuesday.
Health
Jun 26, 2012 |
5 / 5 (1) |
1
Study to measure optimum frequency of blood donation
A study commencing in the same week as World Blood Donor Day will determine whether blood can be safely collected more frequently than present practice.
Other
Jun 15, 2012 |
not rated yet |
0
New Firefly technology lights up more precise kidney sparing surgery
A surgical technology called Firefly is shedding new light on kidney cancers and helping doctors at MedStar Georgetown University Hospital remove tumors more safely and more efficiently while sparing the rest ...
Surgery
Jun 05, 2012 |
4.5 / 5 (2) |
0
World's biggest stroke clot-buster trial reveals patient benefits
(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.
Neuroscience
May 24, 2012 |
5 / 5 (1) |
0
Nonsurgical method to measure brain pressure shows promise
(HealthDay) -- A new nonsurgical method for monitoring brain pressure might help improve treatment of head injury patients, according to a new study.
Medical research
Apr 11, 2012 |
5 / 5 (2) |
0
|
Non-invasive scans accurately predict 30-day risk for patients with chest pain
Coronary CT angiography (CCTA) -- a non-invasive way to look inside arteries that supply blood to the heart -- can quickly and reliably determine which patients complaining of chest pain at an emergency department can safely ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
Aspirin as good as Plavix for poor leg circulation: study
(HealthDay) -- Aspirin works as well as Plavix in patients with blocked leg arteries, a new European study finds.
Cardiology
Feb 22, 2012 |
5 / 5 (1) |
1
Hepatitis C deaths up, baby boomers most at risk
(AP) -- Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed - they are most at risk.
Diseases, Conditions, Syndromes
Feb 20, 2012 |
not rated yet |
3
Stem cell treatments improve heart function after heart attack
Stem cell therapy moderately improves heart function after a heart attack, according to a systematic review published in The Cochrane Library. But the researchers behind the review say larger clinical trials are needed to ...
Medical research
Feb 14, 2012 |
5 / 5 (1) |
0
Donated hearts may beat much longer
New technology increases the length of time that a human heart can remain viable for transplant after removal from a donor for transplantation.
Medical research
Feb 14, 2012 |
5 / 5 (2) |
0
|
